Advertisement

Topics

Perrigo gets tentative FDA approval for Mirvaso gel generic

12:41 EDT 4 Aug 2017 | Drug Store News

The drug is indicated to treat persistent (nontransient) erythema of rosacea in adults ages 18 years and older. 

read more

Original Article: Perrigo gets tentative FDA approval for Mirvaso gel generic

NEXT ARTICLE

More From BioPortfolio on "Perrigo gets tentative FDA approval for Mirvaso gel generic"

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Mirvaso (brimonidine)
MIRVASO® (BRIMONIDINE) TOPICAL GEL, 0.33%* IS THE FIRST & ONLY FDA-APPROVED TREATMENT DEVELOPED AND INDICATED FOR PERSISTENT FACIAL REDNESS OF ROSACEA Mirvaso® (brimonidine) topical gel, 0.33% is an alpha adrenergic agonist indicated for th...